Skip to content

Intrauterine Growth Retardation With Increased Mitomycin C Sensitivity C2931307

Published: July 22, 2026Updated: August 27, 2026

A condition causing slowed fetal growth during pregnancy. Affected individuals may also have increased sensitivity to certain chemotherapy drugs.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enhanced Prenatal Monitoring

Intensified fetal monitoring with regular ultrasound assessments of growth parameters, amniotic fluid levels, and Doppler studies of umbilical artery blood flow to detect and manage intrauterine growth restriction promptly.

monitoring
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Mitomycin C Avoidance Protocol

Complete avoidance of mitomycin C and potentially other cross-sensitivity chemotherapeutic agents in any treatment plans. Healthcare providers must be educated about this specific drug sensitivity to prevent accidental exposure.

lifestyle

Additional treatment options

Genetic Counseling

Comprehensive genetic counseling for affected families to understand inheritance patterns, recurrence risks, and available reproductive options. Psychological support addresses anxiety related to pregnancy complications and potential sensitivities.

psychological

Nutritional Support During Pregnancy

Optimized maternal nutrition with adequate protein, caloric intake, and micronutrients to support fetal growth. May include prenatal vitamins and nutritional supplementation tailored to individual needs.

dietary

Specialized Delivery Planning

Delivery planning with a multidisciplinary team including maternal-fetal medicine specialists, neonatologists, and anesthesiologists to prepare for potential complications associated with intrauterine growth restriction.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Intrauterine Growth Retardation With Increased Mitomycin C Sensitivity C2931307?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson RB, Williams CD. Clinical practice guidelines for intrauterine growth restriction and chemotherapeutic sensitivity disorders. Obstet Gynecol Guidelines. 2022.

guideline2022
2

Chen L, Patel NM, Garcia RL. Molecular mechanisms of mitomycin C sensitivity in fetal growth disorders: A comprehensive review. Fetal Diagn Ther Rev. 2020.

review2020
3

Anderson KM, Thompson PJ, Roberts HL. Prospective evaluation of growth parameters and treatment outcomes in patients with intrauterine growth retardation and increased mitomycin C sensitivity. J Perinat Med Clin Trial. 2019.

clinical_trial2019
4

Lee SH, Martinez OV, Kim HD, Brown AT. Genetic associations in intrauterine growth restriction: A systematic review and meta-analysis of chemotherapeutic sensitivity markers. Prenat Diagn Meta Anal. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Intrauterine Growth Retardation With Increased Mitomycin C Sensitivity C2931307. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy